Geron (GERN) Research & Development (2010 - 2026)
Geron's (GERN) quarterly Research & Development came in at $15.0 million in Q1 2026, down 0.81% year-on-year from $15.1 million in Q1 2025, and up 10.38% quarter-over-quarter from $13.5 million in Q4 2025.
Geron (GERN) Research & Development (2010 - 2026) Analysis & Trends
Geron has disclosed Research & Development across 17 years of filings, most recently posting $15.0 million for Q1 2026.
- Research & Development for Q1 2026 came in at $15.0 million, down 0.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $71.3 million (down 20.27% YoY), and the FY2025 annual result was $71.4 million, down 31.14% from the prior year.
- Research & Development came in at $15.0 million for Q1 2026 at Geron, up from $13.5 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $35.5 million in Q2 2023 to a low of $13.5 million in Q4 2025.
- The 5-year median for Research & Development is $23.4 million (2024), against an average of $24.2 million.
- Across the five-year window, Research & Development jumped 72.23% in 2023 and plunged 48.67% in 2025, its largest moves.
- Geron's Research & Development stood at $28.2 million in 2022, then increased by 16.66% to $32.9 million in 2023, then declined by 28.8% to $23.4 million in 2024, then sank by 42.18% to $13.5 million in 2025, then grew by 10.38% to $15.0 million in 2026.
- The last three Research & Development figures came in at $15.0 million (Q1 2026), $13.5 million (Q4 2025), and $21.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -58.00 Mn |
| 10 | Geron | 753,046.88 | 753,046.88 | - | 14.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.96 Mn |
| Dec 31, 2025 | 13.55 Mn |
| Sep 30, 2025 | 21.07 Mn |
| Jun 30, 2025 | 21.74 Mn |
| Mar 31, 2025 | 15.08 Mn |
| Dec 31, 2024 | 23.43 Mn |
| Sep 30, 2024 | 20.15 Mn |
| Jun 30, 2024 | 30.78 Mn |
| Mar 31, 2024 | 29.37 Mn |
| Dec 31, 2023 | 32.91 Mn |
| Sep 30, 2023 | 29.43 Mn |
| Jun 30, 2023 | 35.49 Mn |
| Mar 31, 2023 | 27.22 Mn |
| Dec 31, 2022 | 28.21 Mn |
| Sep 30, 2022 | 24.60 Mn |
| Jun 30, 2022 | 20.61 Mn |
| Mar 31, 2022 | 22.10 Mn |
| Dec 31, 2021 | 24.15 Mn |
| Sep 30, 2021 | 18.53 Mn |
| Jun 30, 2021 | 21.94 Mn |